000276752 001__ 276752
000276752 005__ 20240229155003.0
000276752 0247_ $$2pmid$$apmid:37287580
000276752 0247_ $$2pmc$$apmc:PMC10243870
000276752 0247_ $$2ISSN$$a2632-2498
000276752 0247_ $$2doi$$a10.1093/noajnl/vdac165
000276752 0247_ $$2altmetric$$aaltmetric:149745409
000276752 037__ $$aDKFZ-2023-01133
000276752 041__ $$aEnglish
000276752 082__ $$a610
000276752 1001_ $$aTauziède-Espariat, Arnault$$b0
000276752 245__ $$aPediatric meningiomas: A literature review and diagnostic update.
000276752 260__ $$aOxford$$bOxford University Press$$c2023
000276752 3367_ $$2DRIVER$$aarticle
000276752 3367_ $$2DataCite$$aOutput Types/Journal article
000276752 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1686302125_14894
000276752 3367_ $$2BibTeX$$aARTICLE
000276752 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000276752 3367_ $$00$$2EndNote$$aJournal Article
000276752 500__ $$a#LA:B300#
000276752 520__ $$aMeningiomas have always represented the most frequently observed primary central nervous system (CNS) tumor in adults. Multiple advances concerning the genetic and epigenetic characterizations of adult meningiomas have been made over the last few years, and a new proposition for integrated histo-molecular grading has recently been offered in the literature. Pediatric meningiomas represent a very small proportion of all diagnosed meningiomas. New literature has determined that pediatric meningiomas are clinically, histopathologically, genetically, and epigenetically distinct from their adult counterparts. Herein, we reviewed and performed a synthesis of literature investigating pediatric meningiomas. We then compared and contrasted pediatric meningiomas with their adult counterparts.We performed an extensive review of cases from English-language literature available in Pubmed using the keywords 'pediatric' and 'meningioma' as well as 'children' and 'meningioma'. We reviewed and analyzed fifty-six papers that include 498 cases.This literature review revealed that pediatric meningiomas differ from their adult counterparts clinically (location, sex ratio) and also in terms of etiology (germline mutations), histopathology (a greater incidence of clear cell subtype), molecular biology, and epigenetics.Pediatric meningiomas are, like other brain tumors (such as low-grade and high-grade gliomas), clinically and biologically different from their adult counterparts. Further studies are needed to better understand the tumorigenesis of pediatric meningiomas and to optimize their stratification in terms of outcome and therapeutic strategy.
000276752 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000276752 588__ $$aDataset connected to DataCite, PubMed, , Journals: inrepo02.dkfz.de
000276752 650_7 $$2Other$$ameningioma
000276752 650_7 $$2Other$$apediatric
000276752 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b1$$udkfz
000276752 7001_ $$aMawrin, Christian$$b2
000276752 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b3$$eLast author$$udkfz
000276752 773__ $$0PERI:(DE-600)3009682-0$$a10.1093/noajnl/vdac165$$gVol. 5, no. Suppl 1$$nSuppl 1$$p105-111$$tNeuro-oncology advances$$v5$$x2632-2498$$y2023
000276752 909CO $$ooai:inrepo02.dkfz.de:276752$$pVDB
000276752 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000276752 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000276752 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000276752 9141_ $$y2023
000276752 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-12
000276752 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-12
000276752 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOL ADV : 2022$$d2023-10-27
000276752 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000276752 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000276752 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000276752 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-11-23T11:49:35Z
000276752 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-11-23T11:49:35Z
000276752 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2022-11-23T11:49:35Z
000276752 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000276752 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2023-10-27
000276752 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000276752 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-27
000276752 9202_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x0
000276752 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000276752 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000276752 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x2
000276752 980__ $$ajournal
000276752 980__ $$aVDB
000276752 980__ $$aI:(DE-He78)B062-20160331
000276752 980__ $$aI:(DE-He78)HD01-20160331
000276752 980__ $$aI:(DE-He78)B300-20160331
000276752 980__ $$aUNRESTRICTED